Int J Biol Sci 2022; 18(4):1434-1450. doi:10.7150/ijbs.57178 This issue Cite

Research Paper

CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability

Fei Liu1,2,#, Qianying Han1,#, Ting Zhang1, Fen Chang1, Jingcheng Deng1, Xiaotian Huang1, Weiping Wang3, Yongjie Xu1, Qin Li1, Luzheng Xu4, Bo Zhang2, Wentong Li5, Li Li1, Yanrong Su6, Yang Li1, Genze Shao1✉

1. Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China
2. Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China
3. Department of Biochemsitry; School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China
4. Medical and Health Analysis Center, Peking University, Beijing, 100191, China
5. Department of Pathology, Weifang Medical University, Shandong, 261041, China
6. The Irma H. Russo, MD Breast Cancer Research Laboratory, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, 19111, USA
# These authors contribute equally to the article

Citation:
Liu F, Han Q, Zhang T, Chang F, Deng J, Huang X, Wang W, Xu Y, Li Q, Xu L, Zhang B, Li W, Li L, Su Y, Li Y, Shao G. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability. Int J Biol Sci 2022; 18(4):1434-1450. doi:10.7150/ijbs.57178. https://www.ijbs.com/v18p1434.htm
Other styles

File import instruction

Abstract

Graphic abstract

BRCA1 is frequently down-regulated in breast cancer, the underlying mechanism is unclear. Here we identified DCAF8L1, an X-linked gene product, as a DDB1-Cullin associated Factor (DCAF) for CUL4 E3 ligases to target BRCA1 and BARD1 for proteasomal degradation. Forced expression of DCAF8L1 caused reduction of BRCA1 and BARD1, and impaired DNA damage repair function, conferring increased sensitivity to irradiation and DNA damaging agents, as well as Olaparib, a PARPi anticancer drug; while depletion of DCAF8L1 restored BRCA1 and suppressed the growth of its xenograft tumors. Furthermore, the expression of DCAF8L1 was induced in human H9 ES cells during transition from primed to naïve state when Xi chromosome was reactivated. Aberrant expression of DCAF8L1 was observed in human breast fibroadenoma and breast cancer. These findings suggest that CRL4DCAF8L1 is an important E3 ligase that may participate in the development of breast cancer, probably through regulating the stability of BRCA1 and BARD1 tumor suppressor, linking BRCA1 and X chromosome inactivation to breast carcinogenesis.

Keywords: BRCA1, BARD1, DCAF8L1, ubiquitination, breast cancer, X chromosome inactivation


Citation styles

APA
Liu, F., Han, Q., Zhang, T., Chang, F., Deng, J., Huang, X., Wang, W., Xu, Y., Li, Q., Xu, L., Zhang, B., Li, W., Li, L., Su, Y., Li, Y., Shao, G. (2022). CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability. International Journal of Biological Sciences, 18(4), 1434-1450. https://doi.org/10.7150/ijbs.57178.

ACS
Liu, F.; Han, Q.; Zhang, T.; Chang, F.; Deng, J.; Huang, X.; Wang, W.; Xu, Y.; Li, Q.; Xu, L.; Zhang, B.; Li, W.; Li, L.; Su, Y.; Li, Y.; Shao, G. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability. Int. J. Biol. Sci. 2022, 18 (4), 1434-1450. DOI: 10.7150/ijbs.57178.

NLM
Liu F, Han Q, Zhang T, Chang F, Deng J, Huang X, Wang W, Xu Y, Li Q, Xu L, Zhang B, Li W, Li L, Su Y, Li Y, Shao G. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability. Int J Biol Sci 2022; 18(4):1434-1450. doi:10.7150/ijbs.57178. https://www.ijbs.com/v18p1434.htm

CSE
Liu F, Han Q, Zhang T, Chang F, Deng J, Huang X, Wang W, Xu Y, Li Q, Xu L, Zhang B, Li W, Li L, Su Y, Li Y, Shao G. 2022. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability. Int J Biol Sci. 18(4):1434-1450.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image